Duke-NUS scientists and their collaborators have discovered a potential new treatment for heart failure with preserved ...

At its Pharma Day, Swiss pharmaceutical giant Roche Holdings AG (OTC:RHHBY) outlined five priority therapeutic areas: ...

Highlights,Significant Prescription Increases,: Citi reports a 244% rise in prescriptions for obesity drugs and an 18% ...

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

The companies report early success, with a 161% increase in member enrollment and a 57% boost in engagement in programs that ...

Roche (RHHBY) reportedly sees three obesity/diabetes drug candidates acquired through its takeover of Carmot having the ...

Losing weight can be particularly challenging for Black women in the U.S., but a culturally sensitive weight loss plan could offer valuable support and guidance.

Rivus already announced in August that the trial hit its key endpoint, but today fleshed out that win with some figures.

Analyst Michael Ulz of Morgan Stanley maintained a Buy rating on Viking Therapeutics (VKTX – Research Report), retaining the price target ...

Roche is planning to launch 13 medicines by the end of the decade and cut research costs for new drugs by a fifth, according to a strategy update on Monday.

Obesity—the bad word everyone throws around, but few want to truly understand. The American Academy of Pediatricians thought ...

A clear FDA public education campaign could help shoppers make healthier choices. But it should first pay attention to the ...